Congratulations to UF BME professors, Drs. Benjamin G. Keselowsky and Cherie Stabler, on their election to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows! Representing a select group of the top two percent of medical and biological engineering professionals, the College of Fellows is comprised of outstanding bioengineers in academia, industry and government.
The inductees, who were nominated by their peers, were screened by committees of Fellows within their specialty and were finally elected by the full College as the official Class of 2018. A formal induction ceremony will be held during AIMBE’s Annual Event in Washington, D.C. on April 9, 2018.
Keselowsky was elected for his outstanding contributions to the field of immune engineering, at the interface of biomaterials and immunology. Keselowsky’s research focuses on engineering biomaterial-cell interactions and targeted controlled release of immune modulating factors to direct immune cell function. His lab focuses efforts on both a basic understanding of interactions of immune cells with biomaterials as well as the engineering of biomaterials capable of directing immunological processes. This work has wide-ranging implications in diverse fields such as implanted devices, therapeutic vaccines, tissue engineering and combination products.
Stabler was elected for her outstanding contributions in the design of translational bioactive materials for cellular transplantation, focusing on treatment of type 1 diabetes. Stabler’s research is distinguished by its integration of engineering, biomaterials, and transplantation in a highly translational manner. Stabler’s lab explores building strong interdisciplinary collaborations to integrate biological cues and signals with rationally designed biomaterials. Through this integration, novel platforms can be developed that not only serve to provide the basic framework to the tissue, but to also dynamically interact with and instruct the surrounding host cells and environment on how to respond to the implant. In such a manner, superior implants may be developed that provide elegant and localized control of the implant microenvironment.
AIMBE is a non-profit organization headquartered in Washington, D.C., representing the most accomplished individuals in the fields of medical and biological engineering. In addition to representing the most accomplished in the top 2% of medical and biological engineers, AIMBE represents academic institutions, private industry, and professional engineering societies.
The College of Fellows is comprised of 1,500 bioengineering leaders who have distinguished themselves through their contributions in research, industrial practice and/or education. Since 1991, this group has lead the way for technological growth and advancement in the fields of medical and biological engineering. Fellows have helped revolutionize medicine and related fields to enhance and extend the lives of people all over the world. They have also successfully advocated for public policies that have enabled researchers and business-makers to further the interests of engineers, teachers, scientists, clinical practitioners, and ultimately, patients.
